Zacks boosts Surgery Partners shares: 4 things to know

Zacks upgraded Nashville, Tenn.-based Surgery Partners shares from a “hold” to a “buy” rating, according to Petro Global News.

Advertisement

Here are four things to know:

1. Zacks’ price target on Surgery Partners shares totals $21.

2. On March 10, 2017, Stifel Nicolaus lowered the company’s rating from a “buy” to a “hold.”

3. Surgery Partners has a one-year low of $11.76 and one-year high of $22.85.

4. The market cap is $967.64 million.

More articles on surgery centers:
SurgCenter Development opens 13th center in Florida; Envision Q4 EBITDA totals $208.7M & more – 6 ASC company notes
4 legislative changes for ASC leaders to note
Banner Health: Tucson ASC, other projects will offset financial setbacks

At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.

Advertisement

Next Up in ASC Transactions & Valuation Issues

Advertisement

Comments are closed.